Literature DB >> 27959289

Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam.

Kathryn A Connor1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27959289     DOI: 10.4037/aacnacc2016612

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


× No keyword cloud information.
  2 in total

1.  In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.

Authors:  Peiyao Jia; Ying Zhu; Hui Zhang; Bin Cheng; Ping Guo; Yingchun Xu; Qiwen Yang
Journal:  BMC Microbiol       Date:  2022-10-01       Impact factor: 4.465

2.  Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016).

Authors:  Hui Zhang; Yingchun Xu; Peiyao Jia; Ying Zhu; Ge Zhang; Jingjia Zhang; Simeng Duan; Wei Kang; Tong Wang; Ran Jing; Jingwei Cheng; Yali Liu; Qiwen Yang
Journal:  Antimicrob Resist Infect Control       Date:  2020-10-27       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.